Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients
International Clinical Psychopharmacology, 08/17/09
Sentissi O et al. – The main outcome of this study is that the patients treated with atypical antipsychotics were more reactive to external eating cues, which could partly explain the higher weight gain often reported in these patients.
Methods- Compared 93 individuals treated with atypical antipsychotics, 27 treated with conventional neuroleptics and 33 untreated patients.
- Did not find any difference according to sex, but the mean body mass index varied significantly among the three groups of patients.
- The DEBQ external eating factor was higher in patients treated with atypical antipsychotics than in patients who received conventional neuroleptics (P=0.035).
- The TFEQ disinhibition and DEBQ emotional eating scores tended to change among the three types of treatment.
- Patients with metabolic syndrome (19%) had lower DEBQ external eating scores (P=0.044) and a tendency of higher TFEQ disinhibition scores.
- The TFEQ disinhibition and hunger scores increased according to the body mass index (P=0.003; P=0.017).
Related Articles
Measuring Motivational Characteristics of Courses: Applying Kellers Instructional Materials Motivation Survey to a Web-Based Course
Academic Medicine, 10/30/09
Relevance Score: 69%
Achievement motivation in the social context: Implicit and explicit Hope of Success and Fear of Failure predict memory for and liking of successful and unsuccessful peers
Journal of Research in Personality, 11/13/09
Relevance Score: 68%
Motivation to change risky drinking and motivation to seek help for alcohol risk drinking among general hospital inpatients with problem drinking and alcohol-related diseases
General Hospital Psychiatry, 11/12/09
Relevance Score: 68%
The sensory-discriminative and affective-motivational aspects of pain
Neuroscience & Biobehavioral Reviews, 11/05/09
Relevance Score: 68%
Motivation and its Relationship to Neurocognition, Social Cognition, and Functional Outcome in Schizophrenia
Schizophrenia Research, 10/01/09
Relevance Score: 68%
Today in Anxiety...keeping you current
Receive free subspecialty "5-minute updates" via email
Illness beliefs before cardiac surgery predict disability, quality of life, and depression 3 months later
Journal of Psychosomatic Research, 12/14/09
Treatment of Resistant Obsessive-Compulsive Disorder With Ventral Capsular/Ventral Striatal Gamma Capsulotomy: A Pilot Prospective Study
Journal of Neuropsychiatry and Clinical Neurosciences, 12/14/09
A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine
World Journal of Biological Psychiatry, 12/14/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
World Journal of Biological Psychiatry, 12/14/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
World Journal of Biological Psychiatry, 12/14/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
World Journal of Biological Psychiatry, 12/14/09
Moods and expectancies of female alcohol drinking – an exploratory study
Scandinavian Journal of Caring Sciences, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


